[Hemolytic uremic syndrome--a serious complication of mitomycin treatment].
Arola
O
O
TYKS:n sisätautien klinikka, Turku.
Aho
H
H
Asola
M
M
Kauppila
M
M
Nikkanen
V
V
Voipio-Pulkki
L M
LM
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects; D004347:Drug Interactions; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D016685:Mitomycin / Q000009:adverse effects*; D013629:Tamoxifen / Q000009:adverse effects
D000903:Antibiotics, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D016685:Mitomycin